Sapu Nano is a clinical-stage biotechnology company developing Deciparticle (TM) nanomedicine therapeutics designed to optimize the delivery of hydrophobic oncology agents and peptide-based ...

Sapu Nano, a clinical-stage nanomedicine company, today announced new data demonstrating that its proprietary Deciparticle™ platform enables broad and consistent formulation of structurally diverse ...

Here, conceptual similarities between Mikhail Blagosklonny's hyperfunction theory of aging and Vladimir Dilman's elevation ...

A research team led by Park Hyun-woo, a biochemistry professor at Yonsei University, has introduced a pioneering method in ...

A landmark review published today in Genomic Psychiatry challenges researchers to fundamentally reconsider how the field ...

Detailed price information for Kazia Therapeutics Ltd ADR (KZIA-Q) from The Globe and Mail including charting and trades.

Ipatasertib showed significant activity in patients with AKT1E17K mutations, with a 24.1% objective response rate and a median response duration of 10.1 months. The trial's 6-month progression-free ...

Research indicates every woman’s molecular fertility timer begins ticking before she is born. In A Nutshell Women’s eggs ...

Many investors have profited from the artificial intelligence (AI) trade in 2025. But there have been several up-and-coming ...

Exercise is widely recognized for its health benefits, including reducing the risk of cancer and heart disease. However, the molecular mechanisms behind how exercise may prevent or slow cancer have ...